机构地区:[1]济南大学山东省医学科学院医学与生命科学学院,250062 [2]山东省医学科学院基础医学研究所 [3]山东大学第二医院耳鼻咽喉头颈外科
出 处:《国际肿瘤学杂志》2017年第4期241-245,共5页Journal of International Oncology
基 金:山东省自然科学基金(ZR2013HL028、ZR2014HQ030、ZR2014HM085、ZR2015PC018);山东省大型科学仪器设备升级改造技术研究专项(2013SJGZ09);山东省医学科学院医药卫生科技创新工程;山东省中医药科技发展计划(2015-326)
摘 要:目的 探讨白细胞介素-17(IL-17)对人喉癌细胞Hep-2增殖、凋亡和迁移的作用.方法将IL-17瞬时转染Hep-2细胞,即转染IL-17组,同时设置空载体组(pEGFP-N1)和正常对照组.荧光显微镜观察转染情况,反转录-聚合酶链反应(RT-PCR)和Western blotting分别检测转染前后IL-17 mRNA和蛋白的表达,四甲基偶氮唑蓝(MTT)法检测转染前后细胞增殖能力变化,流式细胞术检测转染前后细胞凋亡变化,细胞划痕修复实验和Transwell小室检测转染前后细胞迁移能力变化.结果 荧光显微镜下可以看到转染空载体pEGFP-N1和转染目的基因IL-17的Hep-2细胞出现绿色荧光.成功转染IL-17后Hep-2细胞在mRNA和蛋白水平均有IL-17的表达.与正常对照组相比,转染48 h后,转染IL-17组细胞的增殖能力明显减弱(0.34±0.03∶0.46±0.04,P=0.006).转染IL-17组细胞凋亡率明显高于正常对照组(26.80%±0.80%∶2.90%±0.31%,P=0.000).细胞划痕修复实验结果显示,转染IL-17组细胞相对划痕宽度明显大于正常对照组(1.59±0.01∶1.36±0.01,P=0.000).Transwell小室迁移实验结果显示,转染IL-17组细胞明显低于正常对照组细胞的迁移数量(26.33±2.08∶49.33±1.53,P=0.000).结论 IL-17能够抑制人喉癌细胞Hep-2的增殖能力,降低其迁移能力,增强其凋亡.因此,IL-17可通过多种途径抑制喉癌的发生发展.Objective To investigate the effects of interleukin-17 (IL-17) on the cell proliferation, apoptosis and migration of human laryngeal carcinoma Hep-2 cells.Methods IL-17 was transiently transfected into Hep-2 cells, and at the same time empty vector group (pEGFP-N1) and normal control group were set up.The efficiency of transfection was evaluated by fluorescence microscope, and the mRNA and protein expressions of IL-17 were detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting.The proliferation of cells was detected by methyl thiazolyl tetrazolium (MTT) method, and the apoptosis was detected by flow cytometry.The migration ability was detected by wound-healing assay and Transwell assay.ResultsHep-2 cells transfected with empty vector pEGFP-N1 and IL-17 showed green fluorescence under the fluorescence microscope.Hep-2 cells expressed IL-17 at both mRNA and protein levels after transfection with IL-17.Compared with the normal control group, the proliferation of IL-17 transfected Hep-2 cells was significantly inhibited after 48 h transfection (0.34±0.03 vs.0.46±0.04, P=0.006).The apoptotic rate of IL-17 transfected cells was higher than that of normal control group (26.80%±0.80% vs.2.90%±0.31%, P=0.000).According to the wound-healing assay, compared with the normal control group, the scratch width of IL-17 transfected cells was significantly greater (1.59±0.01 vs.1.36±0.01, P=0.000).Transwell migration experiment showed that the migration of IL-17 transfected cells was significantly lower than that of the normal control group (26.33±2.08 vs.49.33±1.53, P=0.000).Conclusion IL-17 can inhibit the proliferation of human laryngeal carcinoma Hep-2 cells, reduce their migration ability and enhance their apoptosis ability.Therefore, IL-17 may inhibit the occurrence and development of laryngeal carcinoma through a variety of mechanisms.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...